Form D · Other Health Care
Getlabs, Inc.
Miami, FL · CIK 0001878407
Offering snapshot reported Aug 14, 2023 · SEC filing
- Reported sold
- $18.7M Offering amount: $36.4M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 31, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 14, 2023 | Initial | $18,686,117 | No comparison | 17 | SEC filing |
| Aug 13, 2021 | Initial | $16,999,991 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-489601
Source: Form D, filed Aug 14, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ryan Batenchuk | Director |
| Matt Bettonville | Director |
| Timothy Connors | Director |
| Demetri Karagas | Director |
| Kyle Michelson | Director, Executive, Promoter |
| David Shin | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
801 Brickell Ave, Floor 8
Miami, FL, 33131
Miami, FL, 33131